AYTU BIOSCIENCE, INC (78) | Business Finance (36)

Browse by Subcategory

Recent Contracts

Form of Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)
Underwriting Agreement, dated as of March 2, 2022, by and between Aytu BioPharma, Inc. and Canaccord Genuity LLC (Filed With SEC on March 4, 2022)
Loan and Security Agreement dated January 26, 2022 between the registrant and the Avenue Capital Lenders and Avenue Capital Agent (Filed With SEC on February 14, 2022)
Restricted Stock Award Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)
Closing Certificate with respect to the July 1, 2021 Asset Purchase Agreement, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)
Promissory Note, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)
Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Filed With SEC on March 22, 2021)
Commitment Letter, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc. and Encina Business Credit, LLC (Filed With SEC on December 10, 2020)
Form of Restricted Stock Cancelation and Exchange Agreement (Filed With SEC on July 2, 2020)
Registration Rights Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
Form of Security Holder Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
Form of Prefunded Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)
Asset Purchase Agreement, dated July 1, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on September 28, 2021)
Asset Purchase Agreement, dated April 12, 2021 (Filed With SEC on May 17, 2021)
Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,... (Filed With SEC on March 22, 2021)
Amended and Restated Underwriting Agreement, dated December 10, 2020, between Aytu BioScience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 14, 2020)
Form of Wainwright Warrant (Filed With SEC on July 2, 2020)
Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 20, 2020)
Form of Warrant (Filed With SEC on March 20, 2020)
Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)
Form of Warrant (Filed With SEC on March 13, 2020)
Form of Securities Purchase Agreement, dated March 10, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)
Form of Pre-Funded Purchase Warrant (Filed With SEC on March 13, 2020)
Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 7, 2019)
Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
First Amendment to Asset Purchase Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)
Form of Registration Rights Agreement (Filed With SEC on October 15, 2019)
Form of Securities Purchase Agreement (Filed With SEC on October 15, 2019)
Form of Common Stock Purchase Warrant (Filed With SEC on October 15, 2019)
Asset Purchase Agreement, dated October 10, 2019 (Filed With SEC on October 15, 2019)
Form of Amendment No. 1 to Securities Purchase Agreement, dated April 24, 2019 (Filed With SEC on April 26, 2019)
Form of Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock (Filed With SEC on February 7, 2019)
Waiver of Blocker dated February 5, 2019 (Filed With SEC on February 7, 2019)
Form of Warrant (Filed With SEC on February 7, 2019)
Exchange Agreement dated February 5, 2019 (Filed With SEC on February 7, 2019)